VOL. XCIV, NO. 247

★ FINANCIAL TOOLS & SERVICES DIRECTORY ★

PRICE: 5 CENTS

Sunday, October 5, 2025

View EstimizeView Portfolio123Back to Home

Head-to-head

Estimize vs Portfolio123 comparison

Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.

Quick takeaways

Estimize adds Alerts, Analyst Forecasts, and Inflation Rates coverage that Portfolio123 skips.

Portfolio123 includes Quant, Backtesting, Portfolio, Correlation, APIs & SDKs, Broker Connectors, and Data Visualizations categories that Estimize omits.

Estimize highlights: Crowdsourced EPS and revenue estimates on a non-GAAP basis, with more than 120,000 contributors and coverage of over 3,000 stocks and 80+ macro indicators each quarter., Earnings and economic calendars (including CPI and PPI) with the ability for users to submit their own estimates., and Premium subscription provides access to the complete Estimize dataset without the need to contribute, plus advanced screening tools and customizable alerts ($99/month)..

Portfolio123 is known for: Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry., Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data., and Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging..

Estimize logo

Estimize

estimize.com

Crowdsourced earnings and macro estimates platform. The free community tier lets you view and contribute forecasts, while Premium ($99/month) unlocks the full dataset without contributing, plus screening and alerts. Enterprise clients can access data through real-time APIs, daily FTP feeds, or Excel files. A public REST API exists for community data.

Platforms

Web
API

Pricing

Free
Subscription

Quick highlights

  • Crowdsourced EPS and revenue estimates on a non-GAAP basis, with more than 120,000 contributors and coverage of over 3,000 stocks and 80+ macro indicators each quarter.
  • Earnings and economic calendars (including CPI and PPI) with the ability for users to submit their own estimates.
  • Premium subscription provides access to the complete Estimize dataset without the need to contribute, plus advanced screening tools and customizable alerts ($99/month).
  • APIs and data delivery: a public REST API with some open endpoints, plus enterprise delivery via real-time API, daily FTP, or daily Excel files.
  • Embeddable Estimize widget available for third-party sites.

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
View full profileVisit site
Portfolio123 logo

Portfolio123

portfolio123.com

Editor’s pick Hands-on review

Quant research and live-deployment platform with point-in-time fundamentals and estimates. Users can screen, backtest, and simulate strategies, then deploy them live with broker integrations. Supports API access and a no-code desktop DataMiner. FactSet or S&P Compustat licenses are required for full historical fundamentals.

Platforms

Web
Desktop
API

Pricing

Free
Subscription

Quick highlights

  • Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry.
  • Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data.
  • Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging.
  • ‘Books’ feature to combine multiple strategies and view correlations between them.
  • Point-in-time fundamentals, estimates, and corporate actions with dividends handled on ex/pay dates (no survivorship bias or look-ahead).

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
View full profileVisit site
Overlap

Shared focus areas

3 overlaps

Mutual strengths include Screeners, Calendar, and Data APIs.

Where they differ

Estimize

Distinct strengths include:

Alerts
Analyst Forecasts
Inflation Rates
  • Crowdsourced EPS and revenue estimates on a non-GAAP basis, with more than 120,000 contributors and coverage of over 3,000 stocks and 80+ macro indicators each quarter.
  • Earnings and economic calendars (including CPI and PPI) with the ability for users to submit their own estimates.
  • Premium subscription provides access to the complete Estimize dataset without the need to contribute, plus advanced screening tools and customizable alerts ($99/month).
  • APIs and data delivery: a public REST API with some open endpoints, plus enterprise delivery via real-time API, daily FTP, or daily Excel files.

Portfolio123

Distinct strengths include:

Quant
Backtesting
Portfolio
Correlation
APIs & SDKs
Broker Connectors
Data Visualizations
  • Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry.
  • Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data.
  • Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging.
  • ‘Books’ feature to combine multiple strategies and view correlations between them.

Feature-by-feature breakdown

AttributeEstimizePortfolio123
Categories

Which research workflows each platform targets

Shared: Screeners, Calendar, Data APIs

Unique: Alerts, Analyst Forecasts, Inflation Rates

Shared: Screeners, Calendar, Data APIs

Unique: Quant, Backtesting, Portfolio, Correlation, APIs & SDKs, Broker Connectors, Data Visualizations

Asset types

Supported asset classes and universes

Stocks

Stocks, ETFs

Experience levels

Who each product is built for

Beginner, Intermediate, Advanced

Beginner, Intermediate, Advanced

Platforms

Where you can access the product

Web, API

Web, Desktop, API

Pricing

High-level pricing models

Free, Subscription

Free, Subscription

Key features

Core capabilities called out by each vendor

Unique

  • Crowdsourced EPS and revenue estimates on a non-GAAP basis, with more than 120,000 contributors and coverage of over 3,000 stocks and 80+ macro indicators each quarter.
  • Earnings and economic calendars (including CPI and PPI) with the ability for users to submit their own estimates.
  • Premium subscription provides access to the complete Estimize dataset without the need to contribute, plus advanced screening tools and customizable alerts ($99/month).
  • APIs and data delivery: a public REST API with some open endpoints, plus enterprise delivery via real-time API, daily FTP, or daily Excel files.
  • Embeddable Estimize widget available for third-party sites.
  • Gamified forecasting with leagues, rankings, and leaderboards to measure analyst accuracy.

Unique

  • Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry.
  • Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data.
  • Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging.
  • ‘Books’ feature to combine multiple strategies and view correlations between them.
  • Point-in-time fundamentals, estimates, and corporate actions with dividends handled on ex/pay dates (no survivorship bias or look-ahead).
  • Coverage of 15,000+ equities in the U.S., Canada, and Europe, including delisted stocks and spinoffs.
Tested

Verified by hands-on testing inside Find My Moat

Not yet

Yes

Editor pick

Featured inside curated shortlists

Standard listing

Highlighted

Frequently Asked Questions

Which workflows do Estimize and Portfolio123 both support?

Both platforms cover Screeners, Calendar, and Data APIs workflows, so you can research those use cases in either tool before digging into the feature differences below.

Do Estimize and Portfolio123 require subscriptions?

Both Estimize and Portfolio123 keep freemium access with optional paid upgrades, so you can trial each platform before committing.

How can you access Estimize and Portfolio123?

Both Estimize and Portfolio123 prioritize web or desktop access. Investors wanting a mobile-first workflow may need to rely on responsive web views.

What unique strengths set the two platforms apart?

Estimize differentiates itself with Crowdsourced EPS and revenue estimates on a non-GAAP basis, with more than 120,000 contributors and coverage of over 3,000 stocks and 80+ macro indicators each quarter., Earnings and economic calendars (including CPI and PPI) with the ability for users to submit their own estimates., and Premium subscription provides access to the complete Estimize dataset without the need to contribute, plus advanced screening tools and customizable alerts ($99/month)., whereas Portfolio123 stands out for Build custom multi-factor ranking systems and rank stocks by universe, sector, or industry., Spreadsheet-style screening with formulas (including Piotroski F-Score) across current and historical data., and Backtesting with realistic assumptions for slippage, commissions, buy/sell rules, position sizing, and hedging..

Keep exploring

Stay on top of related tools

Browse the categories and profiles that overlap most with this comparison to round out your shortlist.

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.